PREVENTION AND TREATMENT OF OSTEOPOROSIS IN COMORBID PATIENTS-Reference-Cited by-同舟云学术

PREVENTION AND TREATMENT OF OSTEOPOROSIS IN COMORBID PATIENTS

Published:2024-08-08 Issue:6 Volume:35 Page:13-21
ISSN:2587-7305
Container-title:Vrach
language:
Short-container-title:Vrach

Author:

Potupchik T.¹,Veselova O.¹,Tutynin A.¹,Pronkina A.²,Monina M.³,Kireeva E.³

Affiliation:

1. Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia

2. Penza state University

3. S.M. Kirov Military Medical Academy, Saint Petersburg

Abstract

The article analyzes the effectiveness of existing drugs for the treatment and prevention of osteoporosis. The role of calcium and vitamin D in bone tissue homeostasis is shown. Special attention is paid to one of the urgent pharmacological and therapeutic problems – polypragmasia associated with comorbidity. Research data demonstrate that drugs for the basic therapy of cardiovascular diseases do not have undesirable interactions with drugs for the treatment of osteoporosis and, in general, many of them have a positive effect on bone metabolism and bone strength. One of the solutions to the problems associated with the treatment of osteoporosis may be the use of biologically active additives Osteomed, Osteo-Vit D3, Osteomed Forte.

Publisher

Russian Vrach, Publishing House Ltd.

Reference79 articles.

1. Cosman F., de Beur S.J., LeBoff M.S. et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014; 25 (10): 2359–81. DOI: 10.1007/s00198-014-2794-2

2. Tański W., Kosiorowska J., Szymańska-Chabowska A. Osteoporosis – risk factors, pharmaceutical and non-pharmaceutical treatment. Eur Rev Med Pharmacol Sci. 2021; 25 (9): 3557–66. DOI: 10.26355/eurrev_202105_25838

3. Лесняк О.М., Баранова И.А., Белова К.Ю. и др. Остеопороз в Российской Федерации: Эпидемиология, медико-социальные и экономические аспекты проблемы (обзор литературы). Травматология и ортопедия России. 2018; 24 (1): 155–68 [Lesnyak O.M., Baranova I.A., Belova K.Yu. et al. Osteoporosis in the Russian Federation: Epidemiology, medical, social and economic aspects of the problem (literature review). Travmatologiia i ortopediia Rossii. 2018; 24 (1): 155–68 (in Russ.)]. DOI: 10.21823/2311-2905-2018-24-1-155-168

4. Salari N., Ghasemi H., Mohammadi L. et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021; 16: 609. DOI: 10.1186/s13018-021-02772-0

5. Добровольская О.В., Торопцова Н.В., Лесняк О.М. Экономические аспекты осложненного остеопороза: стоимость лечения в течение первого года после перелома. Современная ревматология. 2016; 10 (3): 29–34 [Dobrovolskaya O.V., Toroptsova N.V., Lesnyak O.M. Economic aspects of complicated osteoporosis: the cost of treatment during the first year after the fracture. Sovremennaya revmatologiya. 2016; 10 (3): 29–34 (in Russ.)]. DOI: 10.14412/1996-7012-2016-3-29-34